MacroGenics Announces Sale of TZIELD™ Royalty Interest for
ROCKVILLE, MD, March 08, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company
Globe Newswire9-03-2023, 05:48
nCino Announces Stock Repurchase Program 2-04-2025, 03:05